fingolimod hydrochloride has been researched along with Dermatoses in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sadik, CD; Thieme, M; Zillikens, D | 1 |
| Kabashima, K; Sakabe, J; Sugita, K; Tanizaki, H; Tokura, Y; Yoshiki, R | 1 |
1 review(s) available for fingolimod hydrochloride and Dermatoses
| Article | Year |
|---|---|
Sphingosine-1-phosphate modulators in inflammatory skin diseases - lining up for clinical translation.
Topics: Animals; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lymphocytes; Lysophospholipids; Receptors, Lymphocyte Homing; Receptors, Lysophospholipid; Skin Diseases; Sphingosine; Thiazoles | 2017 |
1 other study(ies) available for fingolimod hydrochloride and Dermatoses
| Article | Year |
|---|---|
FTY720 regulates bone marrow egress of eosinophils and modulates late-phase skin reaction in mice.
Topics: Animals; Blotting, Western; Bone Marrow; Cell Movement; Chemotaxis; Disease Models, Animal; Eosinophils; Female; Fingolimod Hydrochloride; Flow Cytometry; Humans; Immunosuppressive Agents; Inflammation; Interleukin-5; Lymph Nodes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Propylene Glycols; Receptors, Lysosphingolipid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin; Skin Diseases; Sphingosine | 2010 |